INTRODUCTION
Endometrial, cervical and ovarian carcinomas are the most common three gynecologic malignancies of the world. These malignancies are the leading causes of mortality and morbidity in women after breast cancer. Even so, endometrial carcinoma has the highest curability within the most common 10 female malignancies (1) . The detection of these malignancies depends on clinical findings and diagnostic imaging methods. The first imaging method for a suspected gynecologic malignancy is ultrasonography which is used to confirm a mass, identify the originating organ and characterize the mass. Despite the useful information accuired with US, magnetic resonance imaging (MRI) is superior because of its soft tissue contrast especially in uterin and cervical lesions (2) and used as a problem solving modality in patients with sonographically undetermined lesions (3) .
Conventional MRI has been widely accepted as a valid imaging modality for gynecologic masses. Although the morphologic features of a lesion like solid component or papillary projections for ovarian carcinoma and signal intensity changes for endometrial or cervical carcinoma would be helpful in differentiating a lesion, microstructural changes which would be helpful for characterizing a lesion can not be evaluated with conventional MRI. Diffusion weighted imaging (DWI) is a noninvasive MRI technique which is promising for showing microstructural changes, early tumor detection and evaluation of treatment responce (4) . There are numerous studies investigating the accuracy of DWI in differentiating benign lesions from ovarian cancer (5-7), endometrial cancer (8, 9) , and cervical cancer (10) (11) (12) . However there is not one study available in the literature which investigates the accuracy of DWI in differentiating malignant from benign lesions which include most of gynecologic lesions. The aim of the present study was to investigate the accuracy of DWI in differentiation of malignant from benign gynecologic masses.
PATIENTS and METHODS
A total of 125 female patients who referred to our department for pelvic MRI with a suspected gynecologic mass between October 2007 and October 2008 were included in this study. All patients gave written informed consent for MRI examination. This study was approved by our instutitional review board.
From the study patients, 67 were operated and 58 were followed up. According to the histopathologic evaluation and follow up results, the final diagnosis was malignant for 35 lesions and 90 lesions benign. The malignant lesions were endometrial carcinoma in 5 patients (4%) cervical carcinoma in 12 patients (9.6%) and ovarian carcinoma in 18 patients (14.4%). The benign lesions were leiomyom in 28 patients (22.4%), endometrioma in 12 patients (9.6%), hemorrhagic ovarian cyst in 12 patients (9.6%), follicular cyst in 11 patients (8.8%), lymphocel in 9 patients (7.2%), dermoid tumour in 8 patients (6.4%), benign ovarian tumour in 5 patients (4%), and nabothi cyst in 5 patients (4%) ( Table 1) .
MR examination
All patients underwent pelvic MRI with a 1.5 Tesla MR unit (Signa Hispeed Excite General Electric, Milwaukee, WI). The patients were examined in supine position. Diffusionweighted MR images were obtained by a 4-channel phased array coil for body, using an echo planar imaging in the axial plane without breath holding in approximately 30 seconds. A three-plane gradient echo localizer sequence was performed at the beginning of the examination. Imaging parameters were repetition time (TR)/ echo time (TE): 8000/80 ms; section thickness: 5 mm; intersection gap: 0; matrix size: 128 x 128; field of view: 300 x 300 mm, water excitations with b values of 100, 600 and 1000 s/mm 2 for DWI. Axial T2 weighted spin-echo sequences (TR/TE= 4100/95, section thickness: 5 mm; intersection gap: 1 mm) were also performed for lesion detection. T2 weighted images were used for detection of lesion and lesion diameters. Colorcoded ADC maps were automatically created by the diffusion difference between gradients b 100, b 600 and b 1000 s/mm 2 Lesions were divided into two major groups according to histopathological analyses and follow-up results as malignant lesions and benign lesions. Calculated ADC values for b values of 100, 600 and 1000 s/mm 2 were compared for major groups and subgroups.
Statistical analyses
Data was summarized as mean ± standard deviation for continuous variables and frequencies for categorical variables. Mann Whitney U test was used for independent group comparisons depending on the distributional properties of the data. A p value <0.05 was considered as statistically significant. In order to determine the diagnostic accuracy of ADC measurements, ROC analysis was performed. Cut-off ranges were calculated around the optimal cut-off to maximize sensitivity and specificity for discrimination of malignant from benign gynecologic lesions. Youden index J values were used to compare diagnostic accuracy of ADC measeurements in different b values.
RESULTS
A total of 125 female patients with mean age of 39 (range: 16-75) were included in this study. The final diagnosis was made according to histopathologic evaluation (n= 67) or follow up results (n=58). Lesions were divided into two major groups; malignant lesions (n= 35) and benign lesions (n=90).
The mean and standard deviation (SD) of ADC values (x10 -3 mm 2 /s) of all lesions were 2.48±0.9 for b 100, 1.89±0.7 for b 600, and 1.63±0. (Table 4 ). According to these analyses, ADC value at b 1000 was found to have the highest accuracy for differentiation of malignant from benign gynecologic masses (Table 2, Figure 3 ). 
DISCUSSION
Decreased ADC values have been reported in various malignities which can be explained by the increased cellular density of tissue (13) (14) (15) sensitivity of 57% and a specificity of 77%, and 0.9x10 -3 mm 2 /s for b 1000 with a sensitivity of 57% and a specificity of 91%. According to these analyses, ADC value at b 1000 was found to have the highest accuracy for differentiation of malignant from benign gynecologic masses.
There are some limitations in this study. The total cohort has a sufficient sample size; however, subgroup size is quite small. The lesions included in this study have heterogeneity such as being cystic or solid. However, our purpose was to differentiate malignant lesions from benign ones, independent of lesions' nature and other imaging findings.
In conclusion, we observed significantly lower ADC values in gynecologic malignant lesions in all b values with the highest accuracy for ADC value at b 1000. According to our study, ADC measurements can be used for differentiation of malignant from benign gynecologic lesions.
